Cite
HARVARD Citation
Oliva, A. et al. (n.d.). P2‐039: PROGRESS OF THE PHASE I CLINICAL TRIAL TO EVALUATE LONGEVERON ALLOGENEIC MESENCHYMAL STEM CELLS (LMSCS) AS A POTENTIAL THERAPEUTIC FOR ALZHEIMER'S DISEASE. Alzheimer's & dementia. p. P586. [Online].